Journal profile · Endocrinology & Metabolism
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
ISSN 1389-9155 · eISSN 1573-2606 · Springer US · NETHERLANDS · Quarterly · Founded 2000
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS: CAS Zone 2 · Medicine (2025 upgraded edition); impact factor 8.68; hybrid open access; APC about USD 5,590; median 77 days to acceptance (45 articles, last 24 months); community-reported acceptance: moderate; 72 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS is published by Springer US and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Growth Hormone and Insulin-like Growth Factors, Diet and metabolism studies and Pituitary Gland Disorders and Treatments, together about 24.5% of its articles. Its main subfields are Endocrinology, Diabetes and Metabolism. (generated from OpenAlex topic counts and CAS ranking data)
Reviews in Endocrine and Metabolic Disorders is an international journal dedicated to students, clinicians and researchers involved in the broad area of endocrinology and metabolism. This field of medicine and biology is rapidly advancing and a major challenge is to keep abreast of the advances in the field.The mission of this review journal is to keep those interested individuals informed of all the latest exciting advancements that are essential to their research or clinical practice.The format of this review journal differs from existing journals. Each of the quarterly issues covers a specific topic. Ten to twelve articles will be published by world leaders in this area. The individual papers are brief overviews of the latest developments, with insight into the basic aspects of the disease and translation into clinical aspects. Thus the student, academic clinician and practicing clinician will be able to understand the disease process and apply this knowledge to his or her area of interest. Selected readings and other essential references will enable the reader to investigate a particular topic in a more in-depth approach. Reviews in Endocrine and Metabolic Disorders considers both unsolicited and invited review articles from authors for publication in the journal.
From the journal's Aims & Scope
Research area (LetPub): Endocrinology & Metabolism
Editor-in-chief Felipe F. CasanuevaPublisher website
Editorial board by country: 1 in mainland China (about 2%); most named Italy 13, United States 12, Spain 7, United Kingdom 3, France 3 (64 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Growth Hormone and Insulin-like Growth FactorsMedicine8.8%
- Diet and metabolism studiesMedicine8.2%
- Pituitary Gland Disorders and TreatmentsMedicine7.6%
- Adipose Tissue and MetabolismMedicine5.9%
- Pancreatic function and diabetesMedicine5.3%
- Regulation of Appetite and ObesityNeuroscience5.1%
- Neuroendocrine Tumor Research AdvancesMedicine4.4%
- Vitamin D Research StudiesMedicine4.3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Endocrinology & Metabolism | Zone 2 |
Top journal: noReview journal: yes
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Endocrinology & Metabolism | Zone 1 |
Top journal: yesReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Endocrinology & Metabolism | Zone 2 |
Top journal: noReview journal: yes
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEEmbaseCASCurrent ContentsPublisher website
Other: Google Scholar, EBSCO, ProQuest, Dimensions, CNKI, Baidu, AGRICOLA, Naver, OCLC, Portico, CLOCKSS, Semantic Scholar
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 8.68LetPub ·
- Impact factor (publisher) 2025
- 8.7Publisher website ·
- 5-year impact factor (publisher) 2025
- 9.7Publisher website ·
- CiteScore 2026-06
- 19.2LetPub ·
- SJR 2026-06
- 2.83LetPub ·
- SNIP 2026-06
- 3.23LetPub ·
- h-index
- 64LetPub ·
- h-index
- 128OpenAlex ·
- i10-index
- 976OpenAlex ·
- 2-year mean citedness
- 6.41OpenAlex ·
- Self-citation rate
- 3.4%LetPub ·
- Share of gold OA articles
- 48.18%LetPub ·
Volume
- Articles per year
- 69LetPub ·
- Downloads per year (publisher) 2025
- 876,600Publisher website ·
Articles by year OpenAlex count · 1,285 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 76 | 57 | 59 |
| 2025 | 72 | 45 | 568 |
| 2024 | 69 | 37 | 763 |
| 2023 | 89 | 49 | 3,016 |
| 2022 | 81 | 53 | 3,208 |
| 2021 | 80 | 50 | 4,187 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
77 daysMedian, submission to acceptance · P25–P75 55 days – 100 days
- Acceptance to online
- median 15 days (97 articles)
- Submission to online
- median 102 days
- Sample
- 45 articles with submission and acceptance dates (178 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- over 12 weeksLetPub ·
- Average acceptance (community reports)
- ModerateLetPub ·
- Submission to first decision
- 6 daysPublisher website ·
- Peer review
- Double anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 5,590 / EUR 4,490 / GBP 3,790 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare5 items from the author guidelines
- Abstract
- 150–250 words
- Keywords
- ≥ 4
- Manuscript length
- ≤ 7,000 words
- Reference style
- Numbered, in order of citation
- Suggested reviewers
- Optional
Article types accepted3
- editorialEditorial Procedure The journal publishes three categories of review articles: thematic, solicited and unsolicited reviews. The first two categories address aut…Length not stated
- reviewEditorial Procedure The journal publishes three categories of review articles: thematic, solicited and unsolicited reviews. The first two categories address aut…Length not stated
- review articleEditorial Procedure The journal publishes three categories of review articles: thematic, solicited and unsolicited reviews. The first two categories address aut…Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Open access, Peer review, Trial registration / reporting guidelines
- AI use Generative AI Images
Please check Springer’s policy on generative AI images and make sure your work adheres to the principles described therein. Back to top
Source ↗Publisher website ·- Authorship Authorship principles
These guidelines describe authorship principles and good authorship practices to which prospective authors should adhere to. Authorship clarified The Journal and Publisher assume all authors agreed with the content and that all gave explicit consent to submit and that they obtained consent from the responsible authorities at the institute/organization where the work has been carried out, before th…
Source ↗Publisher website ·- Conflicts of interest Disclosures and declarations
Competing interests disclosure required Model summary
All authors are requested to include information regarding sources of funding, financial or non-financial interests, study-specific approval by the appropriate ethics committee for research involving humans and/or animals, informed consent if the research involved human participants, and a statement on welfare of animals if the research involved animals (as appropriate). The decision whether such …
Source ↗Publisher website ·- Data availability Data availability statements
Data transparency expected Model summary
All original research must include a data availability statement. This statement should explain how to access data supporting the results and analysis in the article, including links/citations to publicly archived datasets analysed or generated during the study. Please see our full policy here. If it is not possible to share research data publicly, for instance when individual privacy could be com…
Source ↗Publisher website ·- Publication ethics Compliance with Ethical Standards
To ensure objectivity and transparency in research and to ensure that accepted principles of ethical and professional conduct have been followed, authors should include information regarding sources of funding, potential conflicts of interest (financial or non-financial), informed consent if the research involved human participants, and a statement on welfare of animals if the research involved an…
Source ↗Publisher website ·- License & copyright Copyright
Open Choice articles do not require transfer of copyright as the copyright remains with the author. In opting for open access, the author(s) agree to publish the article under a Creative Commons license. Details of the OA licences offered to authors can be found on the individual journal website, in the journal's How to publish with us guide. Back to top
Source ↗Publisher website ·- Open access Open access publishing
To find out more about publishing your work Open Access in Reviews in Endocrine and Metabolic Disorders, including information on fees, funding and licences, visit our Open access publishing page. Back to top
Source ↗Publisher website ·- Peer review COVID-19 and impact on peer review
As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time…
Source ↗Publisher website ·- Trial registration / reporting guidelines Clinical Trial Registration
The World Health Organization (WHO) definition of a clinical trial is "any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes". The WHO defines health interventions as “A health intervention is an act performed for, with or on behalf of a person or population whose purpose is to ass…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Springer US
- Country or region
- NETHERLANDS
- Language
- English
- Frequency
- Quarterly
- Founded
- 2000
- ISSN
- 1389-9155
- Electronic ISSN
- 1573-2606
- Latest issue on the website
- Volume 27, Issue 4 (August 2026)
- Official links
- Journal homepage ↗LetPub
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
What CAS zone is REVIEWS IN ENDOCRINE & METABOLIC DISORDERS in?
In the 2025 upgraded edition of the CAS Journal Ranking, REVIEWS IN ENDOCRINE & METABOLIC DISORDERS is in Zone 2 of Medicine, and in Zone 2 of the minor category Endocrinology & Metabolism. In the 2026 Xinrui edition it is in Zone 1 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of REVIEWS IN ENDOCRINE & METABOLIC DISORDERS?
The latest impact factor listed by LetPub is 8.68; CiteScore 19.2, h-index 128.
How long does peer review take at REVIEWS IN ENDOCRINE & METABOLIC DISORDERS?
Based on the dates recorded on 45 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 77 days (interquartile range 55–100 days); authors report an average review time of over 12 weeks; the community-reported acceptance is “Moderate”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of REVIEWS IN ENDOCRINE & METABOLIC DISORDERS?
According to the journal's author guidelines: Abstract: 150–250 words; Keywords: ≥ 4; Manuscript length: ≤ 7,000 words; Reference style: Numbered, in order of citation; Suggested reviewers: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of REVIEWS IN ENDOCRINE & METABOLIC DISORDERS based?
Of the 64 board members whose country the journal's board page names, 1 (about 2%) are in mainland China; the countries named most often are Italy (13), United States (12) and Spain (7). Counted from the institutions listed on the board page; for reference only.
Which databases index REVIEWS IN ENDOCRINE & METABOLIC DISORDERS?
According to LetPub and DOAJ records, REVIEWS IN ENDOCRINE & METABOLIC DISORDERS is indexed in SCIE and Scopus. The journal's website also lists MEDLINE, Embase, CAS and Current Contents; that list has not been checked against each database.
Is REVIEWS IN ENDOCRINE & METABOLIC DISORDERS open access, and what is the APC?
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS is a hybrid journal. For open-access publication: APC about USD 5,590.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .